Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia

New England Journal of Medicine

Volumn 332, Issue 23, 1995, Pages 1546-1551

  Candeliere, G Antonio ^a   Glorieux, Francis H ^a   Prud'homme, Josée ^b   Arnaud, René ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE;

ADOLESCENT; ALBRIGHT SYNDROME; ARTICLE; BONE BIOPSY; CHILD; CLINICAL ARTICLE; FEMALE; FIBROUS DYSPLASIA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; ONCOGENE C FOS; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTO ONCOGENE; RICKETS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROUS DYSPLASIA OF BONE; GENE EXPRESSION; GENES, FOS; HUMAN; IN SITU HYBRIDIZATION; MALE; MIDDLE AGE; OSTEITIS DEFORMANS; PROTO-ONCOGENE PROTEINS C-FOS; RICKETS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0029006890     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199506083322304     Document Type: Article

References (27)

1. Wallach S Paget's disease and fibrous dysplasia. Curr Opin Rheumatol 1991; 3: 472-480
2. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325: 1688-1695
3. Malchoff CD, Reardon G, MacGillivray DC, Yamase H, Rogol AD, Malchoff DM An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the GS α-subunit from a bone lesion. J Clin Endocrinol Metab 1994; 78: 803-806
4. Shenker A, Weinstein LS, Sweet DE, Spiegel AM An activating GsãŽÂ± mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994; 79: 750-755
5. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989; 340: 692-696
6. Abate C, Curran T Encounters with Fos and Jun on the road to AP-1. Semin Cancer Biol 1990; 1: 19-26
7. Johnson RS, Spiegelman BM, Papaioannou V Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 1992; 71: 577-586
8. Wang Z-Q, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF Bone and haematopoietic defects in mice lacking c-fos. Nature 1992; 360: 741-745
9. Ruther U, Garber C, Komitowski D, Muller R, Wagner EF Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 1987; 325: 412-416
10. Cole DEC, Fraser FC, Glorieux FH, Panostotic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia. Am J Med Genet 1983; 14: 725-735
11. Glorieux FH, Marie PJ, Pettifor JM, Delvin EE Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 1980; 303: 1023-1031
12. Zeller R, Rogers M. In situ hybridization to cellular RNA. In: Ausubel FM, Brent R, Kingston RE, et al., eds. Current protocols in molecular biology. New York: John Wiley, 1989:14.3.1– 14.3.14.
13. Watkins S. Immunohistochemistry. In: Ausubel FM, Brent R, Kingston RE, et al., eds. Current protocols in molecular biology. New York: John Wiley, 1989:14.6.1– 14.6.13.
14. Candeliere GA, Prud'homme J, St-Arnaud R Differential stimulation of fos and jun family members by calcitriol in osteoblastic cells. Mol Endocrinol 1991; 5: 1780-1788
15. Robey PG, Termine JD Human bone cells in vitro. Calcif Tissue Int 1985; 37: 453-460
16. Lyons J, Landis CA, Harsh G, Two G protein oncogenes in human endocrine tumors. Science 1990; 249: 655-659
17. Hoyland J, Sharpe PT Upregulation of c-fos protooncogene expression in Pagetic osteoclasts. J Bone Miner Res 1994; 9: 1191-1194
18. Schwindinger WF, Francomano CA, Levine MA Identification of a mutation in the gene encoding the α subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 1992; 89: 5152-5156
19. Ruther U, Komitowski D, Schubert FR, Wagner EF c-fos Expression induces bone tumors in transgenic mice. Oncogene 1989; 4: 861-865
20. Wu J-X, Carpenter PM, Gresens C, The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene 1990; 5: 989-1000
21. Yabut SM Jr, Kenan S, Sissons HA, Lewis MM Malignant transformation of fibrous dysplasia: a case report and review of the literature. Clin Orthop 1988; 228: 281-288
22. Grigoriadis AE, Schellander K, Wang Z-Q, Wagner EF Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 1993; 122: 685-701
23. Clapham DE Mutations in G protein-linked receptors: novel insights on disease. Cell 1993; 75: 1237-1239
24. Habener JF Cyclic AMP response element binding proteins: a cornucopia of transcription factors. Mol Endocrinol 1990; 4: 1087-1094
25. Montminy MR, Gonzalez GA, Yamamoto KK Regulation of cAMP-inducible genes by CREB. Trends Neurosci 1990; 13: 184-188
26. Sassone-Corsi P, Visvader J, Ferland L, Mellon PL, Verma IM Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev 1988; 2: 1529-1538
27. Gaiddon C, Boutillier A-L, Monnier D, Mercken L, Loeffler J-P Genomic effects of the putative oncogene GãŽÂ±s: chronic transcriptional activation of the c-fos proto-oncogene in endocrine cells. J Biol Chem 1994; 269: 22663-22671